BDBM503530 N-{trans-3-[(4-{N-[(7S)-4- fluorobicyclo[4.2.0]octa-1,3,5-trien- 7-yl]-N'-hydroxycarbamimidoyl}- 1,2,5-oxadiazol-3- yl)oxy]cyclobutyl}acetamide::US11034661, Example 37

SMILES CC(=O)N[C@H]1C[C@H](Oc2nonc2/C(=N/O)N[C@H]2Cc3ccc(F)cc32)C1

InChI Key InChIKey=OSTVHZNBOXHTKQ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 503530   

TargetIndoleamine 2,3-dioxygenase 1(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 503530BDBM503530(N-{trans-3-[(4-{N-[(7S)-4- fluorobicyclo[4.2.0]oc...)
Affinity DataIC50: 83.4nMAssay Description:HIS-tagged IDO1 protein was recombinantly expressed in Escherichia coli using ZYP5052 autoinduction media supplemented with 500 μM delta aminole...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2021
Entry Details
US Patent